从葡萄糖中生产高水平酸盐的Escherichia coli系统工程
Zhilan Zhang1, Ruyin Chu1, Wanqing Wei1
1School of Biotechnology and Key Laboratory of Industrial Biotechnology of Ministry of Education, Jiangnan University, Wuxi, 214122, China.
Nature communications
|February 3, 2024
概括
工程化大肠杆菌高效地产生酸盐,这是聚合物的关键单体. 这项研究详细介绍了代谢工程和基因优化,以改善微生物细胞工厂中的谷氨酸酸生物合成.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 合成生物学 合成生物学
背景情况:
- 酸是聚和聚胺合成的关键单体.
- 目前的谷氨酸微生物生产方法效率低,限制了工业应用.
研究的目的:
- 从葡萄糖中设计一个微生物细胞工厂,以高效地从葡萄糖中生产酸盐.
- 通过代谢模拟,酶工程和基因过度表达来增强谷氨酸生物合成途径.
主要方法:
- 使用代谢模拟来设计一种过度生产素的大肠杆菌菌株 (Lys5).
- 引入了芳香性 aldehyde合成酶,单胺氧化酶和 aldehyde脱酶 (AMA) 途径.
- 在阿尔代脱酶上进行了理性突变发生,并确定了酸盐耐受性基因cbpA并过度表达.
主要成果:
- 经过工程设计的大肠杆菌Lys5获得了195.9g/L的谷氨酸位.
- 在大肠杆菌AMA06中,AMA路径的引入和酶的优化导致谷氨酸位为88.4g/L,产量为0.42g/g葡萄糖,生产率为1.8g/L·h.
- 一种变异的Mu5化脱酶显示,催化效率增加了50倍.
结论:
- 代谢工程策略显著提高了大肠杆菌中酸盐生产效率.
- 开发的微生物细胞工厂为可持续的谷氨酸酸盐生物合成提供了一个有希望的平台.
- 进一步优化可以提高用于工业应用的酸盐生产.
相关概念视频
Other Glycolytic Pathways
1.2K
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
1.2K
Inducible Operons: lac Operon
2.8K
The lac operon in Escherichia coli is a model for understanding inducible gene regulation and metabolic flexibility. It integrates local control by lactose and global regulation through catabolite repression, enabling E. coli to preferentially metabolize glucose when available and switch to lactose utilization when glucose is scarce.Structure and Function of the lac OperonThe lac operon contains three structural genes: lacZ (β-galactosidase), lacY (lactose permease), and lacA...
2.8K
Bioreactor Controls-III
54
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
54
Scale-Up Processes
82
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
82
Upstream Processing
81
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
81
Production of Pharmaceuticals
66
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
66


